Author/Authors :
Gaznabi, Safwan Department of Internal Medicine - Advocate Illinois Masonic Medical Center, Chicago, USA , Abugroun, Ashraf Department of Internal Medicine - Advocate Illinois Masonic Medical Center, Chicago, USA , Mahbub, Hasan Department of Internal Medicine - Flushing Hospital Medical Center, Flushing, NY, USA , Campos, Enrique Department of Cardiology - Advocate Illinois Masonic Medical Center, Chicago, IL, USA
Abstract :
A 79-year-old male was admitted to the hospital for acute exacerbation of heart failure. The patient had history of atrial fibrillation
and was planned for cardioversion. Preprocedure transesophageal echocardiogram (TEE) revealed a large multilobulated mobile
thrombus in the left atrial appendage. The patient refused warfarin therapy and instead chose to take rivaroxaban. Upon
outpatient follow-up, 3 months later, no visible thrombus was appreciated on repeat TEE. This case demonstrates successful
resolution of left atrial and left atrial appendage thrombi with the use of rivaroxaban. At present time, limited data is available
to support the use of rivaroxaban for treatment of intracardiac thrombi. This case highlights the need for further studies to
investigate the outcomes and relative efficiency of use of direct oral anticoagulants (DOACs) in lysis of intracardiac thrombus.
The benefits of DOACs compared to the standard of therapy could increase patient compliance, reduce length of stay, and
improve treatment efficacy
Keywords :
Large Left Atrial , Left Atrial , Thrombus , Rivaroxaban